isradipine has been researched along with oxidopamine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hasegawa, T; Morita, S; Nabeshima, T; Teraoka, T; Yamada, K | 1 |
Araki, T; Imai, Y; Itoyama, Y; Kato, H; Mizugaki, M; Tanji, H | 1 |
Aubert, I; Berthet, A; Bezard, E; Bloch, B; Cenci, MA; Doudnikoff, E; Hengerer, B; Ittrich, C; Rylander, D; Schuster, S; Surmeier, DJ | 1 |
Cronin, A; Grealy, M | 1 |
Afonso, ND; Chapela, D; Correia, AD; Outeiro, TF; Sousa, S; van der Linde, HC; Vaz, RL; Willemsen, R | 1 |
5 other study(ies) available for isradipine and oxidopamine
Article | Year |
---|---|
Neuropharmacological characterization of voltage-sensitive calcium channels: possible existence of neomycin-sensitive, omega-conotoxin GVIA- and dihydropyridines-resistant calcium channels in the rat brain.
Topics: Animals; Binding Sites; Brain; Calcium; Calcium Channel Blockers; Calcium Channels; Chickens; Corpus Striatum; Dihydropyridines; Dopamine; In Vitro Techniques; Isradipine; Kainic Acid; Male; Neomycin; omega-Conotoxin GVIA; Oxidopamine; Peptides; Rats; Rats, Wistar; Synaptosomes | 1993 |
Sequential changes of [H]forskolin, [H]cyclohexyladenosine and [H]PN200-110 binding sites in the brain of 6-hydroxydopamine-lesioned rats.
Topics: Adenosine; Animals; Autoradiography; Binding Sites; Brain Chemistry; Calcium Channel Blockers; Calcium Channels; Colforsin; Corpus Striatum; Isradipine; Male; Medial Forebrain Bundle; Nerve Degeneration; Oxidopamine; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Substantia Nigra; Sympatholytics; Tritium | 2000 |
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cerebrum; Dendritic Spines; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Enkephalins; Isradipine; Levodopa; Male; Motor Activity; Nimodipine; Oxidopamine; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Sympatholytics | 2009 |
Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson's Disease.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Disease Models, Animal; Dopaminergic Neurons; Drug Administration Schedule; Embryo, Nonmammalian; Indans; Isradipine; Levodopa; Locomotion; Minocycline; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase; Zebrafish | 2017 |
Identification of antiparkinsonian drugs in the 6-hydroxydopamine zebrafish model.
Topics: Amantadine; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopaminergic Neurons; Drug Repositioning; Indans; Isradipine; Larva; Levodopa; Locomotion; Motor Activity; Oxidopamine; Parkinson Disease; Phenotype; Zebrafish | 2020 |